Company news - October 2009

Merger proposal goes to board
Two publicly traded companies, Naturex and Natraceutical Group, have signed a memorandum of understanding regarding the merger of Natraceutical's ingredients division into Naturex, which is expected to be completed before the end of the year. The combination of a complementary-product portfolio, production sites and sales offices all over the world will combine the strengths of Naturex and Natraceutical Group, the company says, and will create the world's leading independent natural speciality-ingredients company. The companies will now initiate the due-diligence process prior to the formalization of a binding contract to be ratified by the respective boards of directors and Naturex's shareholders meeting.

New headquarters for Fluxome
Fluxome has consolidated its Danish operations at Stenlose, a northern suburb of Copenhagen. This new location will house Fluxome's global sales and marketing, administration, and R&D. Fluxome is a growing industrial biotechnology company established in 2002. It is rooted in the Technical University of Denmark. It has, until now, been sharing space at their campus in Lyngby. In addition to the expanded office space, the new location has state-of-the-art laboratory facilities needed for new-product development. The new premises create a highly functional and representative headquarters for the Danish biotech company.

EU approves Colombian fish oil
EssentiOmega fish-oil ingredients, by Originates, have been approved by SANCO to be added to the list of fish-oil products that may be imported for human consumption to the European Union from Colombia. Originates produces products for human nutrition, cosmetics and animal nutrition. The company's fish-oil omega-3 concentrates molecular-distillation plant is located in Colombia, close to the source of Peruvian fish oils. Originates is equipped to meet demand in the US, EU and the international market place, the company says.

Enzymotec opens a new plant
Among the speakers to usher in Enzymotec's new plant opening that took place in July in the Sagi industrial area in Northern Israel was Israeli President Shimon Peres. An estimated 350 guests attended the event at the new state-of-the-art 200,000-square-foot facility. The facility includes several production lines, research laboratories and Enzymotec's main offices. Enzymotec is a biotechnology company that develops and produces innovative biofunctional ingredients to address health needs associated with the human life cycle.

Ulrick and Short plans new line
One of the UK's leading clean-label ingredients developers, suppliers and manufacturers, Ulrick and Short, announced a plan to launch a line of new nutritionally beneficial ingredients later this year. The company joined forces with Appetizing Innovations to prove the efficacy and legality of ingredients with specific health declarations, and to help the company take its first step toward diversifying into clean-label crop-based functional foods, it reports. The company expects the launch to generate around 10-15 per cent of its annual sales revenue by 2015.

Acquisition to up yeast offerings
Lallemand completed the acquisition of Lake States Yeast Division from the Wausau Paper Group. Lake States Yeast will operate as a separate unit within Lallemand, but its product portfolio will be integrated in the Lallemand Bio-Ingredients division providing yeast and yeast extracts produced in Canada, Estonia and Denmark. Lallemand Bio-Ingredients was created as a division of Lallemand Inc in order to produce value-added products to complement the growing need in savoury and nutritional markets.

DSM enzyme wins award
Maxilact, a purified lactase preparation isolated from dairy yeast, has won the 2009 Ringier Technology Innovation Award, given for technical excellence and the product's significant technological contribution to the Chinese food and beverage industry. The prestigious award is coordinated by market-leading publishing house Ringier, and judged by an independent panel of industry professionals. Maxilact converts lactose into digestible sugars for people who are lactose intolerant.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.